期刊文献+

血浆甲壳质酶蛋白40和内皮微粒与老年急性冠状动脉综合征的相关性研究 被引量:6

Correlation of plasma enzyme chitin 40 and endothelial microparticle with acute coronary syndrome in elder patients
下载PDF
导出
摘要 目的:探讨血浆甲壳质酶蛋白40(YKL-40)和内皮微粒(EMP)与老年急性冠状动脉综合征(ACS)之间的相关性。方法:选择行冠状动脉造影检查且年龄≥65岁者180例,随机分为ACS组(n=96)和对照组(n=84)。应用酶联免疫吸附法检测血浆YKL-40水平;应用流式微球技术检测血浆EMP水平,以CD31^+/CD42b-EMPs为标志;采用Gensini评分对每支血管病变狭窄程度进行定量计算。结果:ACS组血浆YKL-40和CD31^+/CD42b-EMPs水平均明显高于对照组(P<0.01)。ACS组患者Gensini评分值与血浆YKL-40和CD31^+/CD42b-EMPs水平均呈正相关关系(r=0.522,P<0.01;r=0.561,P<0.01)。ACS组患者血浆YKL-40水平和CD31^+/CD42b-EMPs水平呈正相关关系(r=0.625,P<0.01)。结论:老年ACS患者血浆YKL-40和EMP水平明显升高,且升高水平与冠脉病变程度有关,提示两者有可能成为诊断ACS的一个新的生化标志物,并为冠状动脉病变程度及危险分层提供参考依据。 Objective:To investigate the correlation of the levels of plasma enzyme chitin 40(YKL-40) and endothelial microparticle (EMP) with the acute coronary syndrome(ACS) in elder patients. Methods:A total of 180 patients(≥65 years old) with coronary angiography were randomly divided into the ACS group(96 cases) and control group(84 cases). The serum levels of plasma YKL-40 and EMP in two groups were measured by Enzyme-linked immunosorbent assays and cytometric bead assay technique labeled by CD31^+/CD42b^-EMPs,respectively. The vascular stenosis degree was quantified by Gensini score. Results:The levels of the YKL-40 and CD31^+/CD42b^-EMPs in ACS group were significantly higher than those in control group(P 〈0. 01). The Gensini score was significantly positive correlation with the levels of YKL-40 and CD31^+/CD42b^-EMPs in ACS group(r=0. 522,P〈0. 01;r=0. 561,P〈0. 01). The level of YKL-40 was significantly positive correlation with the level of CD31^+/CD42b^-EMPs in ACS group(r=0. 625, P〈0. 01). Conclusions:The levels of plasma YKL-40 and CD31^+/CD42b^-EMPs in ACS patients increase significantly,which is related to the vascular lesion degree. The YKL-40 and EMP maybe a new biochemical marker in diagnosing ACS,which can provide a reference in identifying the severity and risk stratification of coronary artery lesions.
作者 李妙男 王洪巨 张宁汝 黄宇理 史晓俊 唐碧 汤阳 LI Miao-nan WANG Hong-ju ZHANG Ning-ru HUANG Yu-li SHI Xiao-jun TANG Bi TANG Yang(Department of Cardiology, The First Affiliated Hospital of Bengbu Medical College, Bengbu Anhui 233004, Chin)
出处 《蚌埠医学院学报》 CAS 2016年第11期1427-1430,共4页 Journal of Bengbu Medical College
基金 安徽省高等学校自然科学研究一般项目(KJ2015B003by) 安徽省高等学校自然科学研究重大项目(KJ2015ZD30) 安徽省科技攻关项目(1501041154)
关键词 冠状动脉疾病 甲壳质酶蛋白40 内皮微粒 老年人 PLASMA ENZYME CHITIN 40 acute coronary syndrome endothelial microparticle elderly
  • 相关文献

参考文献2

二级参考文献12

  • 1Rajendra H. Mehta,Lori Parsons,Sunil V. Rao,Eric D. Peterson.Association of Bleeding and In-Hospital Mortality in Black and White Patients With ST-Segment–Elevation Myocardial Infarction Receiving Reperfusion[J].Circulation.2012(14)
  • 2Robin Mathews,Eric D. Peterson,Shuang Li,Matthew T. Roe,Seth W. Glickman,Stephen D. Wiviott,Jorge F. Saucedo,Elliott M. Antman,Alice K. Jacobs,Tracy Y. Wang.Use of Emergency Medical Service Transport Among Patients With ST-Segment–Elevation Myocardial Infarction: Findings From the National Cardiovascular Data Registry Acute Coronary Treatment Intervention Outcomes Network Registry–Get With the Guidelines[J].Circulation.2011(2)
  • 3Marek Gierlotka,Mariusz Gasior,Krzysztof Wilczek,Michal Hawranek,Janusz Szkodzinski,Piotr Paczek,Andrzej Lekston,Zbigniew Kalarus,Marian Zembala,Lech Polonski.Reperfusion by Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction Within 12 to 24 Hours of the Onset of Symptoms (from a Prospective National Observational Study [PL-ACS])[J].The American Journal of Cardiology.2011(4)
  • 4Giuseppe De Luca,Harry Suryapranata,Jan Paul Ottervanger,Elliott M. Antman.Time Delay to Treatment and Mortality in Primary Angioplasty for Acute Myocardial Infarction: Every Minute of Delay Counts[J].Circulation: Journal of the American Heart Association.2004(10)
  • 5Amsterdam EA, Wenger NK, Brindis RG, et al. 2014 AHA/ ACC guideline for the management of patients with non-ST- elevation acute coronary syndromes., executive summary: a report of the american college of cardiology/american heart association task force on practice guidelines[J]. J Am Coll Cardiol,2014,64(24) : e139-e228.
  • 6Cannon CP, Weintraub WS, Demopoulos LA, et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein II b/Ill a inhibitor tirofiban[J]. N Engl J Med, 2001,344~ 1879-1887.
  • 7de Winter RJ, Windhausen F, Cornel JH, et al. Early invasive versus selectively invasive management for acute coronary syndromes[J]. N Engl J Med,2005,353(11)..1095-1104.
  • 8Fox KA, Poole-Wilson PA, Henderson RA, et al. Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial. Randomized Intervention Trial of unstable Angina[J]. Lancet, 2002,360 (9335) : 743-751.
  • 9Mehta SIR, Cannon CP, Fox KA, et al. Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials[J]. JAMA, 2005,293(23) ~ 2908-2917.
  • 10Fox KA, Clayton TC, Damman P,et al. Long-term outcome of a routine versus selective invasive strategy in patients with non-ST-segment elevation acute coronary syndrome a meta- analysis of individual patient data[J]. J Am Coll Cardiol, 2010,55 (22) : 2435-2445.

共引文献26

同被引文献44

引证文献6

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部